FDA warns: blindness risk on GLP-1s

Companies making popular weight loss drugs, including Ozempic and Wegovy – touted to help curb addiction cravings – must add a warning label about a rare eye condition that can cause blindness, the US Food and Drug Administration said. The FDA warned that non-arteritic anterior ischemic optic neuropathy can cause permanent vision loss, and was reported with all GLP-1 drugs.